Anti-DCAKD monoclonal antibody

Pre-made anti-DCAKD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DCAKD/DCAKD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0668-Ab-1/ GM-Tg-hg-IP0668-Ab-2Anti-Human DCAKD monoclonal antibodyHuman
GM-Tg-rg-IP0668-Ab-1/ GM-Tg-rg-IP0668-Ab-2Anti-Rat DCAKD monoclonal antibodyRat
GM-Tg-mg-IP0668-Ab-1/ GM-Tg-mg-IP0668-Ab-2Anti-Mouse DCAKD monoclonal antibodyMouse
GM-Tg-cynog-IP0668-Ab-1/ GM-Tg-cynog-IP0668-Ab-2Anti-Cynomolgus/ Rhesus macaque DCAKD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0668-Ab-1/ GM-Tg-felg-IP0668-Ab-2Anti-Feline DCAKD monoclonal antibodyFeline
GM-Tg-cang-IP0668-Ab-1/ GM-Tg-cang-IP0668-Ab-2Anti-Canine DCAKD monoclonal antibodyCanine
GM-Tg-bovg-IP0668-Ab-1/ GM-Tg-bovg-IP0668-Ab-2Anti-Bovine DCAKD monoclonal antibodyBovine
GM-Tg-equg-IP0668-Ab-1/ GM-Tg-equg-IP0668-Ab-2Anti-Equine DCAKD monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0668-Ab-1/ GM-Tg-hg-IP0668-Ab-2; GM-Tg-rg-IP0668-Ab-1/ GM-Tg-rg-IP0668-Ab-2;
GM-Tg-mg-IP0668-Ab-1/ GM-Tg-mg-IP0668-Ab-2; GM-Tg-cynog-IP0668-Ab-1/ GM-Tg-cynog-IP0668-Ab-2;
GM-Tg-felg-IP0668-Ab-1/ GM-Tg-felg-IP0668-Ab-2; GM-Tg-cang-IP0668-Ab-1/ GM-Tg-cang-IP0668-Ab-2;
GM-Tg-bovg-IP0668-Ab-1/ GM-Tg-bovg-IP0668-Ab-2; GM-Tg-equg-IP0668-Ab-1/ GM-Tg-equg-IP0668-Ab-2
Products NameAnti-DCAKD monoclonal antibody
Formatmab
Target NameDCAKD
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DCAKD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0668-Ag-1Recombinant multi-species DCAKD protein
    ORF Viral VectorpGMLPm001574mouse Dcakd Lentivirus plasmid
    ORF Viral VectorvGMLPm001574mouse Dcakd Lentivirus particle


    Target information

    Target IDGM-IP0668
    Target NameDCAKD
    Gene ID79877,68087,360639,715841,490930,101082449,508778,100064169
    Gene Symbol and Synonyms3010024O21Rik,6720485C15Rik,DCAKD
    Uniprot AccessionQ8WVC6,Q6AY55,Q3ZBS0
    Uniprot Entry NameDCAKD_HUMAN,DCAKD_RAT,DCAKD_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172992
    Target ClassificationN/A

    The target: DCAKD, gene name: DCAKD, also named as . Predicted to enable dephospho-CoA kinase activity. Predicted to be involved in coenzyme A biosynthetic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.